<Scher is in by far the worst position, because he did not disclose his relationship with NOVC nor his relationship with Proquest. Then there is the potential that he was an oncologist source for the short hedge funds over the years regarding DNDN/Provenge.>
as it is, the stench from Scher not having recused himself from the panel due to his obvious conflicts re: Provenge is bad enough, but if they (congress, CTL, etc.) can dig up enough dirt on this douchebag to prove that he did use his influence to the detriment of Provenge & for the benefit of NOVC & his own pocketbook (perhaps via hedge fund consulting or otherwise) then I hope he fries here before he gets to hell.
then again, it would not surprise me that he felt/feels immune to any possible repercussions of any untoward involvement with delaying/defeating Provenge since he was & apparently still is highly regarded in the scientific community (as it relates to prostate cancer) & his imo reputation gives him sufficient cover for any questionable opinions he might have expressed on Provenge science - would the FDA now publicly admit they wouldn't have granted Scher a waiver if he had disclosed his other conflicts? I strongly doubt it, since that would add to the controversy over their Provenge decision and give more ammunition for those looking to broaden the scope of any investigation to include others (eg. Pazdur, etc.) - no way that FDA & Pazdur support that, imo.
and since the hedge funds are likely also current (and/or potential future) significant campaign contributors, I doubt Scher felt/feels he has much to worry about on that front either.
i suspect he was & still is a smug, self-righteous pompous, self-serving Ahole, like it appears a lot of those in positions of power seem to be these days.
AI
